基于结构的De Novo设计,用于发现针对瘤性突变BRAF的微蛋白抑制剂
Jae Min Ham1, Myeongbin Kim1, Taeho Kim2
1Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsimri-ro, Seong-dong-gu, Seoul 04763, Republic of Korea.
International journal of molecular sciences
|May 25, 2024
概括
研究人员开发了针对BRAF V600E突变的新型小蛋白抑制剂,这是癌症的关键驱动因素. 迷你蛋白76显示出作为癌症治疗新疗法的前景.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- BRAF 激酶通路对细胞反应至关重要,并且经常被像 BRAF V600E 这样的突变过度激活,使其成为癌症标.
- 现有的小分子BRAF抑制剂面临诸多挑战,包括非目标效应和不良药理性质.
研究的目的:
- 为了确定针对致癌性BRAF V600E突变的新型小蛋白抑制剂.
- 为了利用小蛋白质作为癌症治疗的潜在多功能候选药物.
主要方法:
- 采用了基于结构的de novo设计,重点关注与BRAF V600E的结合亲和力和水化能量.
- 从14-3-3蛋白质基结构中产生了39个候选小蛋白质.
- 进行了体外结合和激酶抑制试验.
主要成果:
- 两个小蛋白,63和76,被确定为具有低微分子活性的BRAF V600E新型抑制剂.
- 迷你蛋白76在哺乳动物细胞中专门抑制了MEK1酸化.
- 分析了有助于miniprotein 76功效的结构特征.
结论:
- 迷你蛋白76是一种有前途的化合物,用于开发针对BRAF V600E的新型癌症治疗药物.
- 迷你蛋白为BRAF抑制剂的发展提供了一个可行的替代性支架.
- 这项研究提供了关于BRAF V600E受微蛋白抑制的结构基础的见解.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K